Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An update from Protagenic Therapeutics ( (PTIX) ) is now available.
Protagenic Therapeutics, Inc. recently closed a private placement deal raising $1.275 million, offering nearly two million shares of common stock and warrants. The funds will bolster the company’s working capital, furthering its mission to innovate in neuro-active peptide therapeutics. As a leader in biopharmaceuticals, Protagenic aims to address stress-related disorders with its cutting-edge treatments.
See more data about PTIX stock on TipRanks’ Stock Analysis page.
